A clinical formulation indicated for Heart and Blood Pressure. Consistent use supports the relaxation of blood vessels to aid in maintaining stable heart function.
An angiotensin receptor blocker developed to manage hypertension and intended to alleviate heart-related risks post-heart attack to support cardiovascular health.
Mechanism of Action
It blocks the binding of angiotensin II to AT1 receptors. This relaxes blood vessels and decreases the secretion of aldosterone, lowering pressure.
Route of Administration
Oral
Onset Time
3 hours (full effect 4–8 weeks)
Duration
24 hours
Contraindications
Pregnancy, Concurrent aliskiren use, Severe liver or biliary disease
Severe Adverse Events
Severe hypotension, Kidney failure, High blood potassium, Angioedema
Information for Telmisartan is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
